Voyageur Pharmaceuticals Ltd.
VYYRF
$0.10
$0.0110.23%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.53M | -2.24M | -1.55M | -1.58M | -1.25M |
| Total Depreciation and Amortization | 800.00 | 900.00 | 1.00K | 1.10K | 1.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 574.50K | 645.00K | 525.10K | 502.60K | 313.90K |
| Change in Net Operating Assets | -103.20K | -173.30K | -71.20K | 23.30K | 712.70K |
| Cash from Operations | -2.06M | -1.77M | -1.10M | -1.05M | -224.20K |
| Capital Expenditure | -194.00K | -153.80K | -110.10K | -123.50K | -121.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -194.00K | -153.80K | -110.10K | -123.50K | -121.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.35M | 3.33M | 1.71M | 1.62M | 499.20K |
| Repurchase of Common Stock | -- | -- | -- | -5.60K | -5.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -81.20K | 312.70K | 381.40K | 447.30K | 138.10K |
| Cash from Financing | 2.32M | 2.60M | 1.46M | 1.44M | 467.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | 72.90K | 675.30K | 256.20K | 267.90K | 121.40K |